Promopharm
As of August 28, 2026, Promopharm trades at 1,296 MAD on the Casablanca Stock Exchange. Promopharm operates in the Santé sector.
What does Promopharm do?
Société de Promotion Pharmaceutique du Maghreb (Promopharm) is a Moroccan pharmaceutical laboratory that manufactures and markets generic medicines, parapharmaceutical products and dermocosmetics. It is the Moroccan entity of the Hikma pharmaceutical group, its majority shareholder.
Source: company official website
Promopharm performance
Stock performance over the main periods. Price as of August 28, 2026. Click a period to update the chart.
As of August 28, 2026, Promopharm trades at 1,296 MAD, down 13.6% year to date.
Promopharm ratios
Valuation and profitability ratios, as of August 27, 2026.
Ratios computed from the share price and the latest published financial statements.
Promopharm dividend
Promopharm paid a dividend of 30.00 MAD per share in 2026 for the 2025 financial year, with an ex-dividend date of September 11, 2026 on the Casablanca Stock Exchange. Yuna documents 10 dividend financial years for Promopharm, from the oldest (2011) to the most recent (2025).
| Financial year | Dividend per share | Ex-dividend date |
|---|---|---|
| 2025 paid in 2026 | 30.00 MAD | September 11, 2026 |
| 2022 paid in 2023 | 40.00 MAD | September 11, 2023 |
| 2021 paid in 2022 | 40.00 MAD | July 8, 2022 |
Show 7 earlier financial years
| 2020 paid in 2021 | 30.00 MAD | July 12, 2021 |
| 2016 paid in 2017 | 148.00 MAD | May 9, 2017 |
| 2015 paid in 2016 | 169.00 MAD | May 20, 2016 |
| 2014 paid in 2015 | 80.00 MAD | September 15, 2015 |
| 2013 paid in 2014 | 75.00 MAD | July 17, 2014 |
| 2012 paid in 2013 | 130.00 MAD | July 11, 2013 |
| 2011 paid in 2012 | 45.00 MAD | July 18, 2012 |
Dividend history updated on August 30, 2026.
The funds that own Promopharm
6 Moroccan funds own Promopharm, for 11.2 M MAD of combined assets, 0.9% of market cap. As of the latest published inventory (December 31, 2025).
The list of owning funds
The breakdown of the 6 owning funds and the stock's weight in each portfolio is for subscribers.
Detailed financial analysis of Promopharm
Margins, EV/EBITDA, leverage, sector KPIs and earnings history, for subscribers.
Keep exploring the Moroccan market
Frequently asked questions about Promopharm
Embed this stock on your website
Display this stock's price and performance card on your website, updated with every published session.
Data updated automatically · last update: August 28, 2026
Analyze Promopharm and the whole Casablanca market
Price, ratios, earnings, fund ownership and comparator, with a Yuna subscription.